222 related articles for article (PubMed ID: 21930483)
1. Dedicated everolimus-eluting side branch access system: XIENCE SBA.
Sorop O; Hatten TR; van Beusekom HM; Regar E; Ligthart J; Krabbendam-Peters I; Compas L; van der Giessen WJ
EuroIntervention; 2010 Dec; 6 Suppl J():J155-60. PubMed ID: 21930483
[No Abstract] [Full Text] [Related]
2. Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.
Sato K; Panoulas VF; Kawamoto H; Naganuma T; Miyazaki T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):116-8. PubMed ID: 25616826
[No Abstract] [Full Text] [Related]
3. Optical coherence tomography-based assessment of bifurcation stenting using the Axxessª Biolimus A9ª-eluting stent system.
Hiltrop N; Ughi GJ; Dubois C; Adriaenssens T
EuroIntervention; 2016 Jan; 11(9):1027. PubMed ID: 26788704
[No Abstract] [Full Text] [Related]
4. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
6. 10-year follow-up of the first Cypher stent implanted in human: an invasive evaluation with angiography, intravascular ultrasound, and optical coherence tomography.
Sousa JE; Costa JR; Abizaid A
JACC Cardiovasc Interv; 2010 May; 3(5):556-8. PubMed ID: 20488413
[No Abstract] [Full Text] [Related]
7. Nevo stent: a successful stent makeover.
Belardi JA
Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
[No Abstract] [Full Text] [Related]
8. Optical coherence tomography and intravascular ultrasound of double kissing crush coronary bifurcation stenting.
McGeoch RJ; Tanaka K; Kotowycz MA; Bezerra HG; Džavík V
EuroIntervention; 2014 Jul; 10(3):338. PubMed ID: 24862341
[No Abstract] [Full Text] [Related]
9. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
10. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Lansky AJ; Ng VG; Mutlu H; Cristea E; Guiran JB; Midei M; Newman W; Sanz M; Sood P; Doostzadeh J; Su X; White R; Cao S; Sudhir K; Stone GW
Catheter Cardiovasc Interv; 2009 Nov; 74(5):719-27. PubMed ID: 19530147
[TBL] [Abstract][Full Text] [Related]
11. 3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
Garg S; Serruys P; Onuma Y; Dorange C; Veldhof S; Miquel-Hébert K; Sudhir K; Boland J; Huber K; Garcia E; te Riele JA;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1190-8. PubMed ID: 20129545
[TBL] [Abstract][Full Text] [Related]
12. A case of true left main bifurcation treated with bioresorbable everolimus-eluting stent v-stenting.
Sato K; Latib A; Panoulas VF; Naganuma T; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 Aug; 7(8):e103-4. PubMed ID: 25086841
[No Abstract] [Full Text] [Related]
13. Incomplete arterial healing 8 years after the implantation of sirolimus-eluting stent. In vivo visualization by optical coherence tomography.
Bouki KP; Sakkali EK; Apostolou TS
Catheter Cardiovasc Interv; 2012 Mar; 79(4):625-7. PubMed ID: 21735524
[TBL] [Abstract][Full Text] [Related]
14. Subacute left main coronary stent thrombosis secondary to a large calcium spicule that produced stent malapposition: OCT and IVUS findings.
Carrizo S; Sanchez-Recalde A; Garcia-Blas S; Moreno R
EuroIntervention; 2015 Nov; 11(7):781. PubMed ID: 25366651
[No Abstract] [Full Text] [Related]
15. The AXXESS™ self-expanding biolimus A9™ eluting stent system for coronary bifurcation lesions.
Dubois CL; Wijns W
EuroIntervention; 2010 Dec; 6 Suppl J():J130-4. PubMed ID: 21930477
[No Abstract] [Full Text] [Related]
16. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
17. Instant stent-accentuated 3-dimensional optical coherence tomography of a bifurcation lesion treated with reverse minimum overlapping culotte stenting.
Nakao F
JACC Cardiovasc Interv; 2014 Sep; 7(9):e121-2. PubMed ID: 25129671
[No Abstract] [Full Text] [Related]
18. Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
Onuma Y; Piazza N; Ormiston JA; Serruys PW
EuroIntervention; 2009 Dec; 5 Suppl F():F98-F102. PubMed ID: 22100687
[No Abstract] [Full Text] [Related]
19. Warning: this report does not address heavily calcified coronary arteries.
Butman SM
Catheter Cardiovasc Interv; 2010 Nov; 76(5):643. PubMed ID: 20976745
[No Abstract] [Full Text] [Related]
20. Frequency-domain optical coherence tomography assessment of stent constriction 9 months after sirolimus-eluting stent implantation in a highly calcified plaque.
Fujino Y; Attizzani GF; Nakamura S; Costa MA; Bezerra HG
JACC Cardiovasc Interv; 2013 Feb; 6(2):204-5. PubMed ID: 23428015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
